Acta Clinica Belgica

Our medical research library holds 6 studies published in Acta Clinica Belgica (1984–2022). Each entry links to the study's record on PubMed and, where there is one, to the publisher's page and a free full text. 5 have an abstract, the authors' own summary as PubMed records it: open "Abstract" to read it.

About the journal

• Publisher: Taylor & Francis
• Published: 1946 to the present, England
• Language: English
• ISSN: 1784-3286 (print), 2295-3337 (electronic)
• Its record in the NLM Catalog

2020s

• Airborne pollutants as potential triggers of systemic autoimmune rheumatic diseases: a narrative review. H. Celen, A.C. Dens, S. Ronsmans, et al. 2022;77(5):874-882. Review PubMed · Publisher

  Abstract

  The pathogenesis of systemic autoimmune rheumatic diseases (SARDs) is complex and remains insufficiently understood. It is commonly accepted that both intrinsic and extrinsic environmental factors interact to induce a self-reactive immune response. Case reports and observational studies have revealed an association between SARDs and specific airborne environmental factors, but the heterogeneity of the published studies hampers clear conclusions. The aim of this review is to provide an overview of the available epidemiological evidence on the relationship between airborne pollutants and SARDs. We performed a narrative review using the PubMed database. Observational studies have shown significant associations between airborne pollutants and SARDs. Cigarette smoking is strongly associated with the development of rheumatoid arthritis (RA) while the association between cigarette smoke and the development of other SARDs remains controversial. For decades, silica exposure has been linked to systemic sclerosis (SSc), RA and systemic lupus erythematosus (SLE). There is also strong evidence for a link between solvents and SSc. Recent observations even suggest that ambient air pollution is associated with the development of SARDs. Some studies have shown associations between asbestos, organic dust, metals and pesticides and SARDs, but more studies are needed to confirm these findings. Increasing evidence has linked airborne pollutants to SARDs. Although more studies are needed to understand the potential mechanisms by which these environmental agents contribute to disease pathogenesis, awareness of the link between environmental agents and SARDs is important to recognize and prevent work-related and environmentally induced diseases.

2010s

• Pathologic complete remission of malignant pleural mesothelioma after combined modality treatment: a case report. K. Moubax, V. Van Damme, P. Nafteux, et al. 2013;68(5):386-8. Case report PubMed · Publisher

  Abstract

  A 50-year-old patient with malignant pleural mesothelioma (epithelial subtype, clinically staged cT1bN0M0) underwent a combined modality treatment, including induction chemotherapy, followed by extrapleural pneumonectomy (EPP) and radical radiotherapy. After pathologic examination of the surgical specimen, a complete remission (pT0N0) was observed. The complete disappearance of solid tumour tissue after induction chemotherapy is a rarely observed and documented finding in the combined modality treatment of malignant pleural mesothelioma. The real prognostic value of the pathologic complete remission of a malignant pleural mesothelioma definitely needs to be further evaluated in a larger series of patients.

• 18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours. D.J. De Maeseneer, B. Lambert, V. Surmont, et al. 2010;65(5):291-9. PubMed · Publisher

  Abstract

  Current response guidelines for the treatment of solid tumours are based on CT criteria. Over the last decades new techniques have emerged to evaluate cancer therapy. FDG-PET scanning is a more functional imaging technique, which can measure differences in metabolic activity. Although it has a low specificity, studies show that it can outperform classical CT scanning criteria. Especially in lung, breast and oesophageal cancer it can predict response earlier in the neo-adjuvant setting. This could reduce the use of ineffective cancer therapies, reducing costs and patient toxicity, and direct patients sooner towards effective therapy. The main problem with FDG-PET remains the difficulty in defining thresholds for response, as there is clearly a lack in large prospective randomized studies validating the use of FDG-PET in response guidelines.We give an overview of data on response prediction in solid tumours by the application of PET.

2000s

• An external cause for 'idiopathic' pachymeningitis?. K. Vermeirsch, B. Dubois, R. Sciot, et al. 2006;61(6):355-8. Case report PubMed · Publisher

  Abstract

  In a 67-year-old man with a history of professional asbestos exposure and persistent headaches since one year, a diagnosis of idiopathic pachymeningitis was made. IHCP (idiopathic hypertrophic cranial pachymeningitis) is in literature referred to as one of the presentations of Multifocal Idiopathic Fibrosclerosis or MIF, representing a group of fibro-inflammatory and pathologically similar diseases, including also retroperitoneal fibrosis, mediastinal fibrosis and sclerosing cholangitis. Since recent literature links asbestos exposure to a risk of development of retroperitoneal fibrosis, the present case suggests to focus in future research of IHCP on possible external causes.

1990s

• Malignant peritoneal mesothelioma. Case report and review of the literature. G. Watteeuw, A. D'Hondt, F. Tannouri, et al. 1995;50(4):222-6. Case report · Review PubMed · Publisher

  Abstract

  We describe a peritoneal mesothelioma. There are many aspecific symptoms. Professional exposure is found in only fifty percent of cases. The histological diagnosis is often difficult. The survival period is short because of the absence of curative treatment.

1980s

• Peritoneal mesothelioma: case report and review of the literature. A. Chachati, P. Hoyoux, V. Smoliar. 1984;39(3):141-7. Case report PubMed · Publisher

Browse every journal in the library or the library by type of article, or return to medical research.